Back to GetFilings.com

                                                or

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

    Indicate by check mark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act)

Number of shares of Common Stock, $.01 par value, outstanding as of November 4, 2004: 35,877,223

PART I Financial Information

Item 1. Financial Statements

Consolidated Condensed Statements of Operations Milacron Inc. and Subsidiaries (Unaudited)
		Three Months Ended Sept. 30,							Nine Months Ended Sept. 30,
(In millions, except share and per-share amounts)		2004			2003			2004			2003
Sales		$	180.5		$	170.2		$	561.2		$	542.0
Cost of products sold			144.6			139.0			457.0			447.1
Cost of products sold related to restructuring			1.7			—			1.7			3.8
Total cost of products sold			146.3			139.0			458.7			450.9
Manufacturing margins			34.2			31.2			102.5			91.1
Other costs and expenses
Selling and administrative			30.8			30.7			92.6			95.3
Goodwill impairment charge			—			52.3			—			52.3
Refinancing costs			.4			1.0			21.4			1.0
Restructuring costs			.6			6.4			3.4			14.8
Other expense - net			.5			(1.2	)		1.7			1.0
Total other costs and expenses			32.3			89.2			119.1			164.4
Operating earnings (loss)			1.9			(58.0	)		(16.6	)		(73.3	)
Interest
Income			.6			.2			1.4			1.2
Expense			(7.2	)		(6.1	)		(31.2	)		(18.1	)
Interest-net			(6.6	)		(5.9	)		(29.8	)		(16.9	)
Loss from continuing operations before income taxes			(4.7	)		(63.9	)		(46.4	)		(90.2	)
Provision for income taxes			.8			1.8			3.0			71.4
Loss from continuing operations			(5.5	)		(65.7	)		(49.4	)		(161.6	)
Discontinued operations net of income taxes			—			(2.0	)		(.5	)		(5.7	)
Net loss		$	(5.5	)	$	(67.7	)	$	(49.9	)	$	(167.3	)
Loss per common share — basic and diluted
Continuing operations		$	(.20	)	$	(1.95	)	$	(1.37	)	$	(4.81	)
Discontinued operations			—			(.06	)		(.01	)		(.17	)
Net loss		$	(.20	)	$	(2.01	)	$	(1.38	)	$	(4.98	)
Dividends per common share		$	—		$	—		$	—		$	.02
Weighted-average common shares outstanding assuming    dilution (in thousands)			34,723			33,684			37,333			33,620
See notes to consolidated condensed financial statements.

Notes to Consolidated Condensed Financial Statements
(Unaudited)

Basis of Presentation
      In the opinion of management, the accompanying unaudited Consolidated Condensed Financial Statements contain all adjustments, which consist only of normal recurring adjustments except for the matters discussed in the notes captioned "Discontinued Operations," "Refinancing Costs," "Goodwill Impairment Charge" and "Restructuring Costs," necessary to present fairly the company's financial position, results of operations and cash flows.

      The Consolidated Condensed Balance Sheet at December 31, 2003 has been derived from the audited Consolidated Financial Statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

      The accounting policies followed by the company are set forth in the "Summary of Significant Accounting Policies" note to the Consolidated Financial Statements included in the company's Annual Report on Form 10-K for the year ended December 31, 2003.

Stock-Based Compensation
      The company accounts for stock-based compensation, including stock options, under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," and the related interpretations. Because all stock options outstanding under the company's 1997 Long-Term Incentive Plan (the 1997 Plan) and prior plans have exercise prices equal to the fair market value of the underlying common shares at the respective grant dates, no compensation expense is recognized in earnings. The table that follows illustrates on a pro forma basis the effect on net loss and loss per common share if the stock options granted from 1995 through 2003 had been accounted for based on their fair values as determined under the provisions of Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation."

      The conversion of $30.0 million of Series A Notes into 15.0 million common shares on April 15, 2004 (see Refinancing Transactions) resulted in a change in control under the provisions of the 1997 Plan which triggered the early vesting of all outstanding stock options. Accordingly, the pro forma net loss amount for the nine months ended September 30, 2004 includes a charge of $.7 million in excess of the amount that would otherwise be reported to recognize all remaining compensation expense related to these stock options. As a result of the vesting in the second quarter and the related charge, there is no incremental pro forma expense in the third quarter of 2004.

Discontinued Operations
      In the third quarter of 2002, the company announced a strategy of focusing its capital and resources on building its position as a premier supplier of plastics processing technologies and strengthening its worldwide industrial fluids business. In connection with this strategy, during 2002 the company sold the Valenite, Widia and Werkö metalcutting tools businesses that had been included in its former metalworking technologies segment and initiated plans for the sale of the round metalcutting tools and grinding wheels businesses. The disposition of the round metalcutting tools businesses was completed in the third quarter of 2003 in two separate transactions that resulted in a combined after-tax loss of $6.9 million. The grinding wheels business was sold on April 30, 2004. The company had previously recorded an estimated loss of $4.2 million on the disposition of this business which was adjusted to $3.4 million in the second quarter of 2004 to reflect the actual sale proceeds and sale-related costs.

      The round metalcutting tools and grinding wheels businesses are reported as discontinued operations in the Consolidated Condensed Financial Statements through the dates of their disposition. Operating results for these businesses are presented in the following table.

      As reflected in the preceding table, other allocated costs represent costs directly attributable to the discontinued businesses. Allocated interest expense includes interest on borrowings secured by assets of the businesses sold and an allocated portion of other consolidated interest expense based on the ratio of net assets sold or to be sold to consolidated assets.

      The major classes of assets and liabilities of the discontinued grinding wheels business in the Consolidated Condensed Balance Sheet as of December 31, 2003 are as follows:

Refinancing Costs
      During the first quarter of 2004, the company charged to expense $6.4 million of refinancing costs incurred in pursuing various alternatives to the March 12, 2004 refinancing of approximately $200 million in debt and other obligations (see Refinancing Transactions). The company's refinancing costs in the second quarter totaled $14.6 million, including $5.8 million for the tender offer premium for the 7⁵/₈% Eurobonds due 2005 and the related expenses. The second quarter amount also includes (i) a charge of $2.6 million related to the early vesting of 1,090,310 shares of restricted stock as a result of a change in control provision, (ii) charges of $4.7 million for the write-off of the deferred financing fees related to the credit facility entered into with Credit Suisse First Boston on March 12, 2004 and subsequently repaid on June 10, 2004 and for other refinancing-related costs and (iii) a $1.5 million prepayment penalty for the term loan included in the Credit Suisse First Boston credit facility. An additional $.4 million of expense related to the tender offer was recorded in the third quarter of 2004. In the third quarter of 2003, the company charged to expense $1.0 million of costs incurred in that year in pursuing various alternatives to the 2004 refinancing transactions.

Goodwill Impairment Charge
      In the third quarter of 2003, the company recorded a preliminary goodwill impairment charge of $52.3 million (with no tax benefit) to adjust the carrying value of the goodwill of two businesses included in the mold technologies segment. The amount of the charge was increased to $65.6 million in the fourth quarter after the completion of appraisals of certain tangible and intangible assets. The charge resulted from a downward adjustment of the future cash flows expected to be generated by these businesses due to a delay in the general economic recovery in both North America and Europe. The largest decrease in cash flow expectations related to the company's European mold base and components business due to continued weakness in the markets it serves. The amount of the charge was determined based on a comparison of the present value of expected future cash flows to the value of the assets (including goodwill) and liabilities of the business.

Restructuring Costs
      During 2001, the company's management approved a plan to integrate the operations of EOC and Reform, two businesses that were acquired earlier in that year, with the company's existing European mold base and components business. These businesses are included in the mold technologies segment. The plan, which was substantially completed in 2003, involved the consolidation of the manufacturing operations of five facilities located in Germany and Belgium into three facilities, the reorganization of warehousing and distribution activities in Europe and the elimination of approximately 230 positions. The total cost of the plan was $11.0 million, of which $1.2 million was included in reserves for employee termination benefits that were established in the allocations of the EOC and Reform acquisition costs. The remaining $9.8 million was charged to expense, including $.6 million in the first three quarters of 2003. Of the total cost of the plan, $4.4 million related to employee termination costs, $2.5 million to facility exit costs and $4.1 million to other costs including $3.1 million to relocate employees, inventory and machinery. The cash cost of the integration will be approximately $9.5 million, of which $.2 million and $.1 million was spent in the first three quarters of 2003 and 2004, respectively. Cash costs for the remainder of 2004 are expected to be approximately $.3 million. The non-cash costs of the integration related principally to the write-down of one of the closed facilities to its expected realizable value. As of September 30, 2004 reserves for employee termination benefits and facility exit costs totaled $1.3 million and related principally to supplemental retirement benefits that will be paid to certain former employees in Belgium at a rate of approximately $.1 million per year for the next several years.

      In November 2002, the company announced two restructuring initiatives intended to improve operating efficiency and customer service. The first action involved the transfer of all manufacturing of container blow molding machines and structural foam systems from the plant in Manchester, Michigan to the company's more modern and efficient facility near Cincinnati, Ohio. The mold making operation has also been moved to a smaller location near Manchester. These operations are included in the machinery technologies - North America segment. The relocations, which involved the elimination of approximately 40 positions, are resulting in restructuring costs of $9.7 million, including $3.9 million in the first three quarters of 2003 and $1.8 million in the first three quarters of 2004. An additional $.2 million is expected to be expensed in the fourth quarter of 2004. The 2004 costs relate principally to completing the move of the mold making operation. Of the total cost of $9.7 million, $1.5 million relates to employee severance costs, $2.2 million to facility exit costs including adjustments of the carrying values of assets to be disposed of and plant closing costs, $1.9 million to inventory adjustments related to discontinued product lines and $4.1 million to other move-related costs including employee, inventory and machinery relocation. The cash cost of the relocations will be approximately $5.9 million, (including $1.7 million for severance and termination benefits) $.3 million for plant clean up costs and $3.9 million for other costs, principally to relocate inventory and machinery. The non-cash costs of $3.8 million relate principally to the previously mentioned adjustments related to inventories of discontinued product lines and assets to be disposed of as a result of the plant closure.

      In November 2002, the company also announced that the manufacture of special mold bases for injection molding at the mold technologies segment's Monterey Park, California plant would be phased out and transferred to various other facilities in North America. The closure of the facility resulted in the elimination of 12 positions and restructuring costs of $1.4 million, including $.9 million in 2002 and $.5 million in the first three quarters of 2003. The total cost includes $.1 million for employee termination costs, $.6 million to adjust the carrying values of assets to be sold and plant closure costs and $.8 million for the relocation of equipment and other moving costs. The net cash cost of the closure was $.2 million, which is net of $1.5 million of proceeds from the sale of the facility. The non-cash costs were not significant.

      Early in 2003, the company initiated a plan for the further restructuring of its European blow molding machinery operations at a cost of $4.0 million. A total of $4.6 million was charged to expense for the restructuring in the first three quarters of 2003. In the fourth quarter, $.6 million of excess reserves for termination benefits and inventory adjustments that had been recorded earlier in the year were reversed. The restructuring involved the discontinuation of the manufacture of certain product lines at the plant in Magenta, Italy, which is included in the machinery technologies - Europe segment, and the elimination of approximately 35 positions. The final $4.0 million cost of the restructuring includes $3.3 million to adjust the carrying values of inventories for discontinued product lines to expected realizable values and $.7 million for severance and other termination benefits. The cash cost of the restructuring was $.9 million based on exchange rates in effect when the termination benefits were actually paid. The non-cash cost related almost entirely to the inventory adjustments discussed above.

      In the second quarter of 2003, the company initiated a plan to close the mold technologies segment's special mold base machining operation in Mahlberg, Germany and relocate a portion of its manufacturing operations to another facility. Certain other production was outsourced. The closure resulted in the elimination of approximately 65 positions and restructuring costs of $5.7 million, including $2.8 million to adjust the recorded value of the facility to expected realizable value, $2.3 million for severance and other termination benefits, $.4 million to relocate manufacturing equipment and $.2 million for plant clean up and other costs. The entire cost of the closure was recorded in 2003, including $2.8 million in the second quarter and $.1 million in the third quarter. The cash cost of this initiative was $2.7 million, substantially all of which - principally for severance-related costs - was spent in the second and third quarters of 2003. The non-cash costs of $3.0 million related principally to the write-down of the facility to expected realizable value.

      In the third quarter of 2003, the company announced additional restructuring initiatives that focus on further overhead cost reductions in each of its plastics technologies segments and at the corporate office. These actions, which involve the relocation of production and warehousing (including the closure of one small facility and the downsizing of two others), closures of sales offices, voluntary early retirement programs and general overhead reductions, have resulted in the elimination of approximately 300 positions worldwide. A total of $11.2 million was charged to expense in 2003 in connection with these initiatives and an additional $.5 million to substantially complete them was expensed in the first three quarters of 2004. Of the total cost of the initiatives of $11.7 million, $3.7 million related to the machinery technologies - North America segment, $2.7 million to the machinery technologies - Europe segment, $5.0 million to the mold technologies segment and $.3 million to corporate expenses. The total cost of the 2003 actions includes $3.2 million for supplemental early retirement benefits that will be paid through the company's defined benefit pension plan for certain U.S. employees, $6.8 million for severance and other termination benefits for certain other employees, $.6 million for facility exit costs and $1.1 million for moving expenses. The supplemental early retirement benefits will have the effect of increasing the amount of the company's funding requirements in future years. The cash costs of the initiatives - including $6.9 million for severance and other termination benefits, $.4 million for lease termination and other facility exit costs and $1.2 million for other costs - are expected to total approximately $8.5 million. Of this amount, $3.5 million was spent in 2003 and another $4.4 million was spent in the first three quarters of 2004. Cash costs for the remainder of the year are expected to total approximately $.3 million. The non-cash costs of the 2003 initiatives will be approximately $3.2 million and relate principally to the early retirement benefits funded through the pension plan as discussed above. At September 30, 2004, reserves for the 2003 initiatives, most of which are expected to be utilized in the fourth quarter, totaled $.4 million.

      In the second quarter of 2004, the company initiated additional actions to further enhance customer service while reducing the overhead cost structure of its machinery technologies - North America segment. These overhead reductions resulted in restructuring expense of $.7 million in the second quarter of 2004 and $.4 million in the third quarter. Termination benefits accounted for $.9 million of the total cost. Cash costs are expected to be $1.1 million, of which a total of $.5 million was spent in the second and third quarters of 2004. An additional $.3 million is expected to be spent in the fourth quarter of 2004 with the remainder being spent in 2005. The actions will result in the elimination of approximately 60 positions, all by the end of 2004. Reserves for the 2004 initiatives totaled $.5 million as of September 30, 2004 and are expected to be utilized in the fourth quarter of 2004 and in 2005.

      In the third quarter of 2004, the company elected to discontinue the sale of certain lines of blow molding systems in North America. This decision resulted in a third quarter charge of $1.7 million to adjust the carrying values of the related inventory to net realizable values.

      The following table presents the components of the restructuring costs that are included in the Consolidated Condensed Statements of Operations for the third quarters of 2004 and 2003 and the nine month periods ended September 30, 2004 and 2003.

      The amounts on the line captioned "Inventory adjustments related to product line discontinuation" are included in cost of products sold in the Consolidated Condensed Statements of Operations for the respective periods.

      As presented in the above table, the costs under the line captioned "Costs charged to expense as incurred" do not meet the conditions for accrual under accounting principles generally recognized in the U.S. and are therefore expensed when the related contractual liabilities are incurred. Accordingly, no reserves related to these costs have been established.

      The status of the reserves for the initiatives discussed above is summarized in the following tables. The amounts included therein relate solely to continuing operations.

      Approximately $1.0 million of the $2.5 million of reserves related to restructuring actions is expected to be utilized in the fourth quarter of 2004. An additional $.4 million is expected to be used in the first half of 2005. A large majority of the remaining $1.1 million represents supplemental retirement benefits for certain employees that will be paid at a rate of approximately $.1 million per year for the next several years.

Retirement Benefit Plans
      The tables that follow present the components of expense for all defined benefit pension plans and for postretirement health care costs for the third quarters of 2004 and 2003 and the nine month periods ended September 30, 2004 and 2003.

      The company expects to make contributions to the funded pension plan for certain U.S. employees totaling $4.2 million in 2004. Through the first three quarters, $3.7 million has been paid. Contributions will also be required in future years, including approximately $2.5 million in 2005.

      On December 18, 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) was enacted. Among other things, the Act created new federal subsidies beginning in 2006 for employers that provide prescription drug coverage for their retirees. However, the subsidies will only be available to employers whose prescription drug coverage is determined to be "actuarially equivalent" to Medicare Part D. The principal postretirement health care plan for certain U.S. employees provides prescription drug coverage but due to the absence of definitive regulations for determining actuarial equivalency, the company is currently unable to determine the extent to which the subsidies will be available or their potential effect on postretirement health care costs. The company is evaluating its options regarding the Act, including potential modifications to the plan. However, the amounts presented in the preceding table reflect no adjustments related to the Act.

Income Taxes
      At December 31, 2003, the company had non-U.S. net operating loss carryforwards - principally in The Netherlands, Germany and Italy - totaling $190 million, of which $17 million will expire at the end of 2007. The remaining $173 million have no expiration dates. Deferred tax assets related to the non-U.S. loss carryforwards totaled $61 million at December 31, 2003 and valuation allowances totaling $51 million had been provided with respect to these assets as of that date. Management believes that it is more likely than not that portions of the net operating loss carryforwards in these jurisdictions will be utilized. However, there is currently insufficient positive evidence in some non-U.S. jurisdictions - primarily Germany and Italy - to conclude that no valuation allowances are required.

      At December 31, 2003, the company had a U.S. federal net operating loss carryforward of $63 million, of which $17 million and $46 million expire in 2022 and 2023, respectively. Deferred tax assets related to this loss carryforward, as well as to federal tax credit carryforwards ($13 million) and additional state and local loss carryforwards ($10 million), totaled $45 million. Of the federal tax credit carryforwards, $6 million expire between 2008 and 2014 and $7 million have no expiration dates. Approximately 40% of the state and local loss carryforwards will expire by 2010 and the remainder will expire by 2018. At December 31, 2003, additional deferred tax assets totaling approximately $117 million had also been provided for book deductions not currently deductible for tax purposes including the writedown of goodwill, postretirement health care benefit costs and accrued pension liabilities. The deductions for financial reporting purposes are expecte d to be deducted for income tax purposes in future periods at which time they will have the effect of decreasing taxable income or increasing the net operating loss carryforward. The latter will have the effect of extending the ultimate expiration beyond 2023.

      The conversion of the Series A Notes into common stock on April 15, 2004 and the exchange of such common stock and the Series B Notes for Series B Preferred Stock on June 10, 2004 triggered an "ownership change" for U.S. federal income tax purposes (see Refinancing Transactions). As a consequence of the ownership change, the timing of the company's utilization of tax loss carryforwards and other tax attributes will be substantially delayed. This delay will increase income tax expense and decrease available cash in future years, although the amounts are dependent upon a number of future events and are therefore not determinable at this time.

      Accounting principles generally accepted in the U.S. require that valuation allowances be established when it is more likely than not that all or a portion of recorded deferred tax assets will not be realized in the foreseeable future. The company reviews the need for new valuation allowances and the carrying amounts of previously recorded valuation allowances quarterly based on the relative amount of positive and negative evidence available at the time. Factors considered in these evaluations include management's short-term and long-range operating plans, the current and future utilization of net operating loss carryforwards, the expected future reversal of recorded deferred tax liabilities and the availability of qualified tax planning strategies. Valuation allowances are then established or adjusted as appropriate. The resulting decreases or increases in valuation allowances serve to favorably or unfavorably affect the company's provision for income taxes and effective tax rate.

      At March 31, 2003, management concluded that no valuation allowances were currently required with respect to the company's U.S. deferred tax assets. This conclusion was based on the availability of qualified tax planning strategies and the expectation that increased industrial production and capital spending in the U.S. plastics industry combined with the significant reductions in the company's cost structure that have been achieved in recent years would result in improved operating results in relation to the losses incurred in 2001 and 2002.

      At June 30, 2003, however, management concluded that a recovery in the plastics industry and the company's return to profitability in the U.S. would be delayed longer than originally expected. As a result of these delays and the incremental costs of the restructuring initiatives announced in the third quarter of 2003 (see Restructuring Costs), the company incurred a cumulative operating loss in the U.S. for the three year period ending December 31, 2003. In such situations, accounting principles generally accepted in the U.S. include a presumption that expectations of earnings in the future cannot be considered in assessing the need for valuation allowances. Accordingly, a tax provision of approximately $71 million was recorded in the second quarter of 2003 to establish valuation allowances with respect to a portion of the company's U.S. deferred tax assets for which future income was previously assumed.

      During the second half of 2003, U.S. deferred tax assets increased by approximately $18 million due to continued losses from operations and a goodwill impairment charge, the effects of which were partially offset by taxable income related to dividends from non-U.S. subsidiaries. Valuation allowances were also increased by $18 million. As of December 31, 2003, U.S. deferred tax assets net of deferred tax liabilities totaled $162 million and U.S. valuation allowances totaled $89 million. U.S. deferred tax assets and valuation allowances were both increased by an additional $7 million in the first three quarters of 2004. The company continues to rely on the availability of qualified tax planning strategies and tax carryforwards to conclude that valuation allowances are not required with respect to U.S. deferred tax assets that totaled approximately $73 million at December 31, 2003.

      Management will continue to reassess its conclusions regarding qualifying tax planning strategies and their effect on the amount of valuation allowances that are required on a quarterly basis. This could result in a further increase in income tax expense and a corresponding decrease in shareholders' equity in the period of the change.

      The company recorded a U.S. tax benefit of $2.1 million in the third quarter of 2004 with respect to a portion of its U.S. losses under special carryback provisions. No benefits could be recorded for the remainder of the loss incurred during the first nine months of the year. Certain non-U.S. operations were also precluded from recognizing tax benefits with respect to their losses. However, results for the first nine months of 2004 include tax expense related to operations in profitable non-U.S. jurisdictions. These factors resulted in a provision for income taxes of $3.0 million despite a pretax loss of $46.4 million. In the first three quarters of 2003, the provision for income taxes was $71.4 million which includes the $71 million charge discussed above and provisions for income taxes in certain non-U.S. jurisdictions.

Receivables
      During all of 2003 and through March 12, 2004, the company maintained a receivables purchase agreement with a third party financial institution. Under this arrangement, the company sold, on a revolving basis, an undivided percentage ownership interest in designated pools of accounts receivable. As existing receivables were collected, undivided interests in new eligible receivables were sold. Accounts that became 60 days past due were no longer eligible to be sold and the company was at risk for credit losses for which the company maintained a reserve for doubtful accounts sufficient to cover estimated expenses. At December 31, 2003, approximately $33 million of accounts receivable related to continuing operations had been sold under this arrangement. This amount is reported as a reduction of accounts receivable in the Consolidated Condensed Balance Sheet at that date. On March 12, 2004, all amounts sold by the company under the receivables purchase agreement were repurchased using a portion of the proceeds of the refinancing transactions entered into on that date (see Refinancing Transactions). The effect was to increase the use of cash from operating activities for the nine months ended September 30, 2004 by $33 million.

      Certain of the company's non-U.S. subsidiaries also sell accounts receivable on an ongoing basis. In some cases, these sales are made with recourse, in which case appropriate reserves for potential losses are recorded at the sale date. At September 30, 2004 and December 31, 2003, the gross amounts of accounts receivable that had been sold under these arrangements totaled $3.9 million and $3.8 million, respectively. At September 30, 2004 and December 31, 2003, these amounts were partially collateralized with $3 million of cash deposits that are included in cash and cash equivalents in the Consolidated Condensed Balance Sheets.

      The company also periodically sells with recourse notes receivable arising from customer purchases of plastics processing machinery and, in a limited number of cases, guarantees the repayment of all or a portion of notes from its customers to third party lenders. At September 30, 2004 and December 31, 2003, the company's maximum exposure under these arrangements totaled $7.8 million and $11.6 million, respectively. In the event a customer were to fail to repay a note, the company would generally regain title to the machinery for later resale as used equipment.

      Costs related to sales of notes receivable and to guarantees have not been material in the past.

Goodwill and Other Intangible Assets
      The carrying value of goodwill totaled $83.8 million at both September 30, 2004 and December 31, 2003. The company's other intangible assets, which are included in other noncurrent assets in the Consolidated Condensed Balance Sheets, are not significant.

Other Assets
      The components of other current assets and other noncurrent assets are shown in the tables that follow.

Liabilities
      The components of accrued and other current liabilities are shown in the following table.